Home > Healthcare > Medical Devices > Medical Supplies > Biosensors Market

Biosensors Market Size

  • Report ID: GMI747
  • Published Date: Dec 2022
  • Report Format: PDF

Biosensors Market Size

Biosensors Market size was valued at over USD 28.5 billion in 2022. Driven by rising incidence rates of diabetes across the globe, the market is poised to register over 7% CAGR from 2023 to 2032.

 

Diabetes is among the top chronic health issues that have a profoundly negative impact on public health and socioeconomic progress across the world. Many developed and developing economies have been witnessing a spike in diabetes cases over the last couple of years. In fact, cases of both type 1 and 2 diabetes have risen considerably among children and adolescents during the time. According to current estimates, over 1 million children and adolescents below 20 are suffering from type 1 diabetes.

 

Diabetes is also one of the leading causes of death across the globe, and co-morbidities such as cardiovascular disorders (CVDs), cancer, and respiratory disease are responsible for over 80% of all early fatalities. This growing disease load is subsequently elevating demand for different diagnostic devices such as biosensors to counter the disease and its associated deaths through early diagnosis.

 

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for biosensors was valued at over USD 28.5 billion in 2022 and is projected to grow at over 7% CAGR from 2023 to 2032, fuelled by rising diabetes cases worldwide.

The biosensors industry share from the non-wearable biosensors type segment is slated to grow at over 4.5% CAGR from 2023 to 2032 on account of the increasing prevalence of CVDs, respiratory ailments, and blood pressure-related disorders.

Asia Pacific market for biosensors is slated to depict over USD 16.3 billion by 2032, driven by the rising prevalence of numerous infectious diseases and growing government as well as individual healthcare expenditure in the region.

Some key contenders partaking in the global market share include Siemens Healthineers AG, Danaher Corporation, Ascensia Diabetes Care Holdings AG, Biosensors International Group, Ltd, Bio-Rad Laboratories, Inc, LifeScan Inc., Dexcom, Inc., among others.

Biosensors Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 240
  • Countries covered: 16
  • Pages: 215
 Download Free Sample